Why the study?
MINOCA was increasingly reported among the cardiac complications of COVID-19, motivating a review of reported cases to summarize its clinical features, evaluation, and treatment.
Answers are grounded in this paper and cite their sources.
MINOCA in COVID-19 patients frequently presents with ST-elevation and is associated with a high mortality rate of 37.5%.
Among the cardiac complications of coronavirus disease 2019 (COVID-19), one increasingly reported in the literature is myocardial infarction with non-obstructive coronaries (MINOCA). We reviewed all reported cases of MINOCA in COVID-19 patients to summarize its clinical features, evaluation, and treatment. We performed a literature search in Pubmed using the search terms 'COVID-19' and 'MINOCA' or 'non-obstructive coronaries'. Among the reported cases, the mean age was 61.5 years (SD ± 13.4), and 50% were men. Chest pain was the presenting symptom in five patients (62.5%), and hypertension was the most common comorbidity (62.5%). ST-elevation was seen in most patients (87.5%), and the overall mortality rate was 37.5%. MINOCA in COVID-19 is an entity with a broad differential diagnosis. Therefore, a uniform algorithm is needed in its evaluation to ensure timely diagnosis and management.
No takes yet. Share an insight, caveat, or question.
John et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: